Julia Grapsa

TL;DR: The conclusion should be concise reflecting the status of left ventricular structure and function, the presence of left atrial and/or aortic dilation, right ventricular dysfunction, and pulmonary hypertension, leading to an objective communication with the patient health caregiver.

TL;DR: The present document is an expert consensus from the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association and may serve as a guide for both imagers and electrophysiologists for best selecting the imaging technique and for best interpreting its results in AF patients.

TL;DR: The role of echocardiographic parameters, including global longitudinal strain and three‐dimensional ejection fraction, are proposed and the protocol for baseline pre‐treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2‐targeted therapies such as trastuzumab and vascular endothelial growth factor tyrosine kinase inhibitors are presented.

TL;DR: In this article, the authors evaluated whether 3D-ST would be a reliable method for assessing right ventricular (RV) systolic function and whether strain values were associated with survival.

TL;DR: This guideline protocol aims to outline a practical approach to assessing the probability of pulmonary hypertension using echocardiography and should be used in conjunction with the previously published minimum dataset for a standard transthoracic eChocardiogram.